The first concerns the challenges of validating a RNAi-mediated targeted therapy approach in orthotopic models of glioma and the second concerns the surprising results suggesting that shRNA-mediated silencing of both Rictor and EGFR resulted in a complete eradication of tumors. The gene discussed is EGFR; the disease is glioma.